United Therapeutics (NASDAQ:UTHR) reported quarterly earnings of $7.70 per share which beat the analyst consensus estimate of $7.09 by 8.6 percent. This is a 24.39 percent increase over earnings of $6.19 per share from the same period last year. The company reported quarterly sales of $790.200 million which missed the analyst consensus estimate of $813.077 million by 2.81 percent. This is a 7.38 percent increase over sales of $735.900 million the same period last year.